Treatments for relapsed or refractory rhabdomyosarcoma in children and young people
Posted on Thursday 14 January 2021
CRD Clinical Academic Dr Bob Phillips is leading a new study to understand treatment decision-making processes in families where a child or young person has relapsed/refractory rhabdomyosarcoma. The study is funded by the Children’s Cancer and Leukaemia Group (CCLG) Special Named Funds.
